Edwards Lifesciences Corporation Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security
Edwards Lifesciences Corporation (EW) reported Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security of $300.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities · last filed 2024-02-12
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2022-12-31 was $100.00K, a 0.00% change year-over-year.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2022-09-30 was $0.00.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2022-06-30 was $100.00K, a 99.07% decline year-over-year.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2023 was $300.00K, a 50.00% increase from fiscal 2022.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2022 was $200.00K, a 97.14% decline from fiscal 2021.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2021 was $7.00M, a 58.82% decline from fiscal 2020.
- Edwards Lifesciences Corporation repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2020 was $17.00M, a 41.18% decline from fiscal 2019.
| Period end | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 3 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 6 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 9 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 12 month |
|---|---|---|---|---|
| 2023-12-31 | $300.00K 10-K · filed 2024-02-12 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $100.00K derived: sum of 2 quarters · filed 2024-02-12 | $200.00K derived: sum of 3 quarters · filed 2024-02-12 | $200.00K 10-K · filed 2024-02-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $100.00K derived: sum of 2 quarters · filed 2022-10-28 | $100.00K 10-Q · filed 2022-10-28 | $200.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $100.00K 10-Q · filed 2022-07-29 | $200.00K derived: sum of 3 quarters · filed 2024-02-12 | -$8.50M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | $100.00K derived: sum of 2 quarters · filed 2024-02-12 | -$8.60M derived: sum of 3 quarters · filed 2024-02-12 | $2.10M derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | -$8.60M derived: sum of 2 quarters · filed 2024-02-12 | $2.10M derived: sum of 3 quarters · filed 2024-02-12 | $7.00M 10-K · filed 2024-02-12 |
| 2021-09-30 | -$8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $2.00M derived: sum of 2 quarters · filed 2022-10-28 | $6.90M 10-Q · filed 2022-10-28 | $9.90M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $10.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $15.60M 10-Q · filed 2022-07-29 | $18.60M derived: sum of 3 quarters · filed 2023-02-13 | $20.80M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $4.90M 10-Q · filed 2022-04-28 | $7.90M derived: sum of 2 quarters · filed 2023-02-13 | $10.10M derived: sum of 3 quarters · filed 2023-02-13 | $13.70M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $5.20M derived: sum of 2 quarters · filed 2023-02-13 | $8.80M derived: sum of 3 quarters · filed 2023-02-13 | $17.00M 10-K · filed 2023-02-13 |
| 2020-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $5.80M derived: sum of 2 quarters · filed 2021-10-29 | $14.00M 10-Q · filed 2021-10-29 | $19.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $11.80M 10-Q · filed 2021-07-30 | $17.00M derived: sum of 3 quarters · filed 2022-02-14 | $20.50M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $8.20M 10-Q · filed 2021-04-28 | $13.40M derived: sum of 2 quarters · filed 2022-02-14 | $16.90M derived: sum of 3 quarters · filed 2022-02-14 | $33.10M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $8.70M derived: sum of 2 quarters · filed 2022-02-14 | $24.90M derived: sum of 3 quarters · filed 2022-02-14 | $28.90M 10-K · filed 2022-02-14 |
| 2019-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $19.70M derived: sum of 2 quarters · filed 2020-10-26 | $23.70M 10-Q · filed 2020-10-26 | $624.90M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $16.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $20.20M 10-Q · filed 2020-07-27 | $621.40M derived: sum of 3 quarters · filed 2021-02-12 | $623.30M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $4.00M 10-Q · filed 2020-04-28 | $605.20M derived: sum of 2 quarters · filed 2021-02-12 | $607.10M derived: sum of 3 quarters · filed 2021-02-12 | $1.12B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $601.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $603.10M derived: sum of 2 quarters · filed 2021-02-12 | $1.12B derived: sum of 3 quarters · filed 2021-02-12 | $1.13B 10-K · filed 2021-02-12 |
| 2018-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $519.00M derived: sum of 2 quarters · filed 2019-10-25 | $524.10M 10-Q · filed 2019-10-25 | $529.70M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $517.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $522.20M 10-Q · filed 2019-07-26 | $527.80M derived: sum of 3 quarters · filed 2020-02-14 | $532.40M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $5.10M 10-Q · filed 2019-04-26 | $10.70M derived: sum of 2 quarters · filed 2020-02-14 | $15.30M derived: sum of 3 quarters · filed 2020-02-14 | $470.10M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $10.20M derived: sum of 2 quarters · filed 2020-02-14 | $465.00M derived: sum of 3 quarters · filed 2020-02-14 | $818.40M 10-K · filed 2020-02-14 |
| 2017-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $459.40M derived: sum of 2 quarters · filed 2018-10-26 | $812.80M 10-Q · filed 2018-10-26 | $818.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $454.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $808.20M 10-Q · filed 2018-07-27 | $813.90M derived: sum of 3 quarters · filed 2019-02-15 | $820.30M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $353.40M 10-Q · filed 2018-04-27 | $359.10M derived: sum of 2 quarters · filed 2019-02-15 | $365.50M derived: sum of 3 quarters · filed 2019-02-15 | $375.30M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $12.10M derived: sum of 2 quarters · filed 2019-02-15 | $21.90M derived: sum of 3 quarters · filed 2019-02-15 | $31.40M 10-K · filed 2019-02-15 |
| 2016-09-30 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $16.20M derived: sum of 2 quarters · filed 2017-10-27 | $25.70M 10-Q · filed 2017-10-27 | $36.40M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $19.30M 10-Q · filed 2017-07-28 | $30.00M derived: sum of 3 quarters · filed 2018-02-16 | $34.10M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $9.50M 10-Q · filed 2017-04-28 | $20.20M derived: sum of 2 quarters · filed 2018-02-16 | $24.30M derived: sum of 3 quarters · filed 2018-02-16 | $30.80M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $14.80M derived: sum of 2 quarters · filed 2018-02-16 | $21.30M derived: sum of 3 quarters · filed 2018-02-16 | $29.50M 10-K · filed 2018-02-16 |
| 2015-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $10.60M derived: sum of 2 quarters · filed 2016-10-28 | $18.80M 10-Q · filed 2016-10-28 | $38.80M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $14.70M 10-Q · filed 2016-07-29 | $34.70M derived: sum of 3 quarters · filed 2017-02-17 | $40.80M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $8.20M 10-Q · filed 2016-04-29 | $28.20M derived: sum of 2 quarters · filed 2017-02-17 | $34.30M derived: sum of 3 quarters · filed 2017-02-17 | $168.90M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $26.10M derived: sum of 2 quarters · filed 2017-02-17 | $160.70M derived: sum of 3 quarters · filed 2017-02-17 | $239.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $140.70M derived: sum of 2 quarters · filed 2015-10-29 | $219.00M 10-Q · filed 2015-10-29 | |
| 2014-06-30 | $134.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $212.90M 10-Q · filed 2015-07-29 | ||
| 2014-03-31 | $78.30M 10-Q · filed 2015-04-29 | |||
| 2013-12-31 | $895.40M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $367.50M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |